| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cell adhesion molecule binding | CDH26 TES OBSCN SCYL1 CDH23 ITGA2 PROM1 KIRREL3 FASN NLGN4X PTPRZ1 MYPN DMD HSPA1A MRE11 NLGN4Y TENM4 TNXB | 8.03e-05 | 599 | 213 | 18 | GO:0050839 |
| GeneOntologyMolecularFunction | peptide-glutamate-alpha-N-acetyltransferase activity | 1.13e-04 | 2 | 213 | 2 | GO:1990190 | |
| GeneOntologyMolecularFunction | sulfonylurea receptor activity | 1.13e-04 | 2 | 213 | 2 | GO:0008281 | |
| GeneOntologyMolecularFunction | single-stranded DNA endodeoxyribonuclease activity | 3.16e-04 | 13 | 213 | 3 | GO:0000014 | |
| GeneOntologyMolecularFunction | peptide-serine-alpha-N-acetyltransferase activity | 3.37e-04 | 3 | 213 | 2 | GO:1990189 | |
| GeneOntologyMolecularFunction | denatured protein binding | 3.37e-04 | 3 | 213 | 2 | GO:0031249 | |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | CDH26 CEACAM8 CDH23 KIRREL3 FAT1 MYPN PCDH18 FAT4 PCDHGB2 PCDHGA1 PCDHB14 CELSR2 | 4.58e-07 | 187 | 208 | 12 | GO:0007156 |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | CDH26 CEACAM8 CDH23 KIRREL3 FAT1 MYPN PCDH18 FAT4 PCDHGB2 PCDHGA1 PCDHB14 TENM4 CELSR2 | 1.87e-05 | 313 | 208 | 13 | GO:0098742 |
| GeneOntologyCellularComponent | asymmetric, glutamatergic, excitatory synapse | 9.15e-05 | 24 | 211 | 4 | GO:0098985 | |
| GeneOntologyCellularComponent | perinucleolar chromocenter | 1.01e-04 | 2 | 211 | 2 | GO:0010370 | |
| GeneOntologyCellularComponent | potassium ion-transporting ATPase complex | 3.02e-04 | 3 | 211 | 2 | GO:0031004 | |
| GeneOntologyCellularComponent | RAVE complex | 3.02e-04 | 3 | 211 | 2 | GO:0043291 | |
| Domain | Cadherin_CS | 3.34e-06 | 109 | 206 | 9 | IPR020894 | |
| Domain | CADHERIN_1 | 4.50e-06 | 113 | 206 | 9 | PS00232 | |
| Domain | Cadherin | 4.50e-06 | 113 | 206 | 9 | PF00028 | |
| Domain | CADHERIN_2 | 4.84e-06 | 114 | 206 | 9 | PS50268 | |
| Domain | - | 4.84e-06 | 114 | 206 | 9 | 2.60.40.60 | |
| Domain | CA | 5.20e-06 | 115 | 206 | 9 | SM00112 | |
| Domain | Cadherin-like | 5.58e-06 | 116 | 206 | 9 | IPR015919 | |
| Domain | Cadherin | 6.43e-06 | 118 | 206 | 9 | IPR002126 | |
| Domain | Laminin_G | 4.20e-05 | 58 | 206 | 6 | IPR001791 | |
| Domain | LAM_G_DOMAIN | 5.80e-05 | 38 | 206 | 5 | PS50025 | |
| Domain | Laminin_G_2 | 7.47e-05 | 40 | 206 | 5 | PF02210 | |
| Domain | ARM-type_fold | MON2 PDS5B USP34 SCYL1 TMCO6 TRRAP LYST MROH9 UBR4 PAIP1 CSE1L ARID2 SERAC1 | 1.05e-04 | 339 | 206 | 13 | IPR016024 |
| Domain | LamG | 1.19e-04 | 44 | 206 | 5 | SM00282 | |
| Domain | Sulphorea_rcpt | 1.21e-04 | 2 | 206 | 2 | IPR000388 | |
| Domain | Rav1p_C | 1.21e-04 | 2 | 206 | 2 | IPR022033 | |
| Domain | NLGN4 | 1.21e-04 | 2 | 206 | 2 | IPR030025 | |
| Domain | Rav1p_C | 1.21e-04 | 2 | 206 | 2 | PF12234 | |
| Domain | Sp1_fam | 1.50e-04 | 10 | 206 | 3 | IPR030450 | |
| Domain | - | 6.44e-04 | 95 | 206 | 6 | 2.60.120.200 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | USP34 NAAA ITGA2 SSR1 DMXL1 SORT1 MET FAT1 DNAJC10 SLC5A6 CLPTM1 SCAPER IFI30 TXNDC16 NCEH1 TMX3 NPC1 SEMA3F FAT4 FRAS1 COL12A1 RBM4 DNAJC18 SEC24C CELSR2 P4HA1 MICAL2 | 8.97e-09 | 1201 | 216 | 27 | 35696571 |
| Pubmed | USP34 SETX LIN54 SCYL1 PSMD7 PTBP1 BIRC6 DMXL1 MET FAT1 MGA NOL8 FAT4 MUC16 PKHD1L1 SEC24C SLFN13 STEAP3 PARD3 PRRC1 | 1.02e-07 | 777 | 216 | 20 | 35844135 | |
| Pubmed | 2.36e-07 | 3 | 216 | 3 | 27133716 | ||
| Pubmed | 2.36e-07 | 3 | 216 | 3 | 26431879 | ||
| Pubmed | MON2 USP34 TES DCDC1 VWA8 INPP5K TRRAP ITIH4 FAT1 DNAJC10 SCAPER RARS2 TMX3 MGA MRE11 SIN3A MCTP1 P4HA1 ARID2 NEURL1 MTR PARD3 SENP7 | 5.58e-07 | 1116 | 216 | 23 | 31753913 | |
| Pubmed | Rap2, but not Rap1 GTPase is expressed in human red blood cells and is involved in vesiculation. | 9.41e-07 | 4 | 216 | 3 | 16540189 | |
| Pubmed | 9.41e-07 | 4 | 216 | 3 | 27889927 | ||
| Pubmed | Mutations of the Transcriptional Corepressor ZMYM2 Cause Syndromic Urinary Tract Malformations. | 1.23e-06 | 125 | 216 | 8 | 32891193 | |
| Pubmed | USP34 ERCC4 SETX OBSCN SREBF2 SRP54 PGM1 MYPN TMX3 CPLANE1 MGA PCDH18 NPC1 SHLD2 MRE11 DYRK1A SEC24C VCAN TRAPPC10 MPHOSPH10 PARD3 RAP2C | 1.28e-06 | 1084 | 216 | 22 | 11544199 | |
| Pubmed | VWA8 SCYL1 PTBP1 TRRAP ITIH4 FASN BRCA2 SHPRH DMD MGA HSPA1A SEMA3F FAT4 RAP2A CHERP DNAJC8 SEC24C MPHOSPH10 | 1.33e-06 | 754 | 216 | 18 | 35906200 | |
| Pubmed | SETX NAA10 SRP54 SSR1 TRRAP BIRC6 MET FASN FAT1 DNAJC10 PRRC2C CLPTM1 IFI30 NCEH1 TMX3 HSPA1B NPC1 COL12A1 CHERP UBR4 PAIP1 ATP6V0D1 SEC24C P4HA1 | 2.07e-06 | 1297 | 216 | 24 | 33545068 | |
| Pubmed | 2.34e-06 | 5 | 216 | 3 | 10547281 | ||
| Pubmed | Ubiquitylation by Rab40b/Cul5 regulates Rap2 localization and activity during cell migration. | 2.34e-06 | 5 | 216 | 3 | 35293963 | |
| Pubmed | 2.34e-06 | 5 | 216 | 3 | 18925368 | ||
| Pubmed | Examination of genetic polymorphisms in newborns for signatures of sex-specific prenatal selection. | 3.39e-06 | 101 | 216 | 7 | 20587610 | |
| Pubmed | 4.66e-06 | 6 | 216 | 3 | 16201967 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | MON2 USP34 VWA8 OBSCN TMCO6 TRRAP BIRC6 LYST FASN FAT1 BANP NPC1 SEMA3F FRAS1 RAP2B NICN1 UBR4 DYRK1A GRID1 CELSR2 STEAP3 | 6.23e-06 | 1105 | 216 | 21 | 35748872 |
| Pubmed | PDE3B ACADVL VWA8 SRP54 PSMD7 SSR1 DMXL1 MET DNAJC10 CLPTM1 TMX3 HSPA1A HSPA1B NOL8 DMXL2 FRAS1 DNAJC8 UBR4 DNAJC18 MRPL39 SEC24C P4HA1 MTR STEAP3 PARD3 | 6.69e-06 | 1487 | 216 | 25 | 33957083 | |
| Pubmed | ACADVL PSMD7 LPIN1 FAT1 LPXN SCAPER TMX3 MGA NOL8 MRE11 DMXL2 COL12A1 CTDSPL2 UBR4 C3P1 P4HA1 | 7.40e-06 | 689 | 216 | 16 | 36543142 | |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | PDS5B PDE3B SREBF2 SCYL1 SSR1 SORT1 FASN CLPTM1 ANAPC2 TMX3 WNK3 NPC1 CAPN2 UBR4 DNAJC18 LMBR1 CSE1L P4HA1 MTR | 7.67e-06 | 942 | 216 | 19 | 31073040 |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | SETX ORC3 LIN54 SIX4 TRRAP SORT1 FASN PRRC2C BANP NFYA MGA MRE11 UBR4 DYRK1A SIN3A ORC2 P4HA1 MGME1 | 7.80e-06 | 857 | 216 | 18 | 25609649 |
| Pubmed | A multiprotein complex necessary for both transcription and DNA replication at the β-globin locus. | 7.97e-06 | 21 | 216 | 4 | 20808282 | |
| Pubmed | Elongator and codon bias regulate protein levels in mammalian peripheral neurons. | 8.12e-06 | 7 | 216 | 3 | 29497044 | |
| Pubmed | 8.79e-06 | 77 | 216 | 6 | 10835267 | ||
| Pubmed | 9.26e-06 | 164 | 216 | 8 | 32409323 | ||
| Pubmed | 9.69e-06 | 22 | 216 | 4 | 20965718 | ||
| Pubmed | 1.20e-05 | 170 | 216 | 8 | 15057823 | ||
| Pubmed | SETX EXPH5 SREBF2 PROM1 NFYA DMD CPLANE1 MGA HSPA1A LAMA3 CSE1L CSN1S1 ARID2 | 1.25e-05 | 486 | 216 | 13 | 20936779 | |
| Pubmed | Hsp72 preserves muscle function and slows progression of severe muscular dystrophy. | 1.29e-05 | 8 | 216 | 3 | 22495301 | |
| Pubmed | 1.31e-05 | 172 | 216 | 8 | 27375898 | ||
| Pubmed | 1.32e-05 | 124 | 216 | 7 | 20850016 | ||
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | TES ACADVL PSMD7 ITGA2 SSR1 FASN PRRC2C CLPTM1 NCEH1 HSPA1A HSPA1B CAPN2 UBR4 SEC24C RASEF | 1.46e-05 | 647 | 216 | 15 | 26618866 |
| Pubmed | USP45 and Spindly are part of the same complex implicated in cell migration. | 1.79e-05 | 235 | 216 | 9 | 30258100 | |
| Pubmed | Transcriptome analysis of mouse stem cells and early embryos. | MON2 USP34 NAA10 IREB2 BIRC6 MGA MRE11 COL12A1 RBM4 MAB21L3 SENP7 | 1.90e-05 | 363 | 216 | 11 | 14691545 |
| Pubmed | 2.39e-05 | 187 | 216 | 8 | 26460568 | ||
| Pubmed | Comparative interactome analysis of α-arrestin families in human and Drosophila. | 2.91e-05 | 313 | 216 | 10 | 38270169 | |
| Pubmed | USP34 ERCC4 SETX ORC3 RMI1 BRCA2 TINF2 MGA HSPA1A SHLD2 MRE11 SIN3A | 2.98e-05 | 453 | 216 | 12 | 29656893 | |
| Pubmed | SP2 ERCC4 LIN54 PSMD7 SIX4 TRRAP HDAC3 FAT1 PRRC2C BANP NFYA MGA ASF1A MRE11 DNAH10 RBM4 UBR4 SIN3A MRPL39 C3P1 CSE1L ARID2 MTR | 3.16e-05 | 1429 | 216 | 23 | 35140242 | |
| Pubmed | 3.19e-05 | 253 | 216 | 9 | 29911972 | ||
| Pubmed | 3.76e-05 | 11 | 216 | 3 | 24349473 | ||
| Pubmed | ARD1-mediated Hsp70 acetylation balances stress-induced protein refolding and degradation. | 3.76e-05 | 11 | 216 | 3 | 27708256 | |
| Pubmed | 3.84e-05 | 2 | 216 | 2 | 19246321 | ||
| Pubmed | Exercise induces hepatosplanchnic release of heat shock protein 72 in humans. | 3.84e-05 | 2 | 216 | 2 | 12411538 | |
| Pubmed | 3.84e-05 | 2 | 216 | 2 | 3786141 | ||
| Pubmed | Characterization of the binding between a 70-kDa heat shock protein, HspA1A, and phosphoinositides. | 3.84e-05 | 2 | 216 | 2 | 26923070 | |
| Pubmed | 3.84e-05 | 2 | 216 | 2 | 22220206 | ||
| Pubmed | 3.84e-05 | 2 | 216 | 2 | 26181369 | ||
| Pubmed | 3.84e-05 | 2 | 216 | 2 | 26976620 | ||
| Pubmed | 3.84e-05 | 2 | 216 | 2 | 20235222 | ||
| Pubmed | Genetic determinants of HSP70 gene expression following heat shock. | 3.84e-05 | 2 | 216 | 2 | 20876613 | |
| Pubmed | 3.84e-05 | 2 | 216 | 2 | 20223214 | ||
| Pubmed | 3.84e-05 | 2 | 216 | 2 | 32632164 | ||
| Pubmed | 3.84e-05 | 2 | 216 | 2 | 20093776 | ||
| Pubmed | Bacterial infection elicits heat shock protein 72 release from pleural mesothelial cells. | 3.84e-05 | 2 | 216 | 2 | 23704948 | |
| Pubmed | 3.84e-05 | 2 | 216 | 2 | 23183221 | ||
| Pubmed | 3.84e-05 | 2 | 216 | 2 | 17513788 | ||
| Pubmed | IL-6 activates HSP72 gene expression in human skeletal muscle. | 3.84e-05 | 2 | 216 | 2 | 12207910 | |
| Pubmed | 3.84e-05 | 2 | 216 | 2 | 29572464 | ||
| Pubmed | 3.84e-05 | 2 | 216 | 2 | 17008555 | ||
| Pubmed | 3.84e-05 | 2 | 216 | 2 | 12714332 | ||
| Pubmed | 3.84e-05 | 2 | 216 | 2 | 19299581 | ||
| Pubmed | 3.84e-05 | 2 | 216 | 2 | 16417627 | ||
| Pubmed | 3.84e-05 | 2 | 216 | 2 | 16971451 | ||
| Pubmed | A key role of nuclear factor Y in the refeeding response of fatty acid synthase in adipocytes. | 3.84e-05 | 2 | 216 | 2 | 28281280 | |
| Pubmed | 3.84e-05 | 2 | 216 | 2 | 29631603 | ||
| Pubmed | 3.84e-05 | 2 | 216 | 2 | 1341900 | ||
| Pubmed | Role of membrane Hsp70 in radiation sensitivity of tumor cells. | 3.84e-05 | 2 | 216 | 2 | 26197988 | |
| Pubmed | 3.84e-05 | 2 | 216 | 2 | 21565612 | ||
| Pubmed | 3.84e-05 | 2 | 216 | 2 | 16246175 | ||
| Pubmed | 3.84e-05 | 2 | 216 | 2 | 19157555 | ||
| Pubmed | 3.84e-05 | 2 | 216 | 2 | 37298493 | ||
| Pubmed | Pathobiological implications of mucin (MUC) expression in the outcome of small bowel cancer. | 3.84e-05 | 2 | 216 | 2 | 24722639 | |
| Pubmed | 3.84e-05 | 2 | 216 | 2 | 15498567 | ||
| Pubmed | 3.84e-05 | 2 | 216 | 2 | 18782111 | ||
| Pubmed | Geranylgeranylaceton induces heat shock protein 72 in skeletal muscle cells. | 3.84e-05 | 2 | 216 | 2 | 17482577 | |
| Pubmed | 3.84e-05 | 2 | 216 | 2 | 18434543 | ||
| Pubmed | RBM4 down-regulates PTB and antagonizes its activity in muscle cell-specific alternative splicing. | 3.84e-05 | 2 | 216 | 2 | 21518792 | |
| Pubmed | Isolation of murine hair-inducing cells using the cell surface marker prominin-1/CD133. | 3.84e-05 | 2 | 216 | 2 | 17185982 | |
| Pubmed | 3.84e-05 | 2 | 216 | 2 | 25935522 | ||
| Pubmed | 3.84e-05 | 2 | 216 | 2 | 3019832 | ||
| Pubmed | Sequence analysis of HSPA1A and HSPA1B in a multi-ethnic study population. | 3.84e-05 | 2 | 216 | 2 | 17364813 | |
| Pubmed | 3.84e-05 | 2 | 216 | 2 | 24430435 | ||
| Pubmed | Increased Network Inhibition in the Dentate Gyrus of Adult Neuroligin-4 Knock-Out Mice. | 3.84e-05 | 2 | 216 | 2 | 37080762 | |
| Pubmed | Complex consequences of Cantu syndrome SUR2 variant R1154Q in genetically modified mice. | 3.84e-05 | 2 | 216 | 2 | 33529173 | |
| Pubmed | 3.84e-05 | 2 | 216 | 2 | 29106499 | ||
| Pubmed | 3.84e-05 | 2 | 216 | 2 | 26456829 | ||
| Pubmed | 3.84e-05 | 2 | 216 | 2 | 28504721 | ||
| Pubmed | Nlgn4 knockout induces network hypo-excitability in juvenile mouse somatosensory cortex in vitro. | 3.84e-05 | 2 | 216 | 2 | 24104404 | |
| Pubmed | The septic shock associated HSPA1B1267 polymorphism influences production of HSPA1A and HSPA1B. | 3.84e-05 | 2 | 216 | 2 | 15232679 | |
| Pubmed | Heat shock protein 72 supports extracellular matrix production in metastatic mammary tumors. | 3.84e-05 | 2 | 216 | 2 | 38703814 | |
| Pubmed | 3.84e-05 | 2 | 216 | 2 | 22989184 | ||
| Pubmed | 3.84e-05 | 2 | 216 | 2 | 15748471 | ||
| Pubmed | 3.84e-05 | 2 | 216 | 2 | 20849898 | ||
| Pubmed | 3.84e-05 | 2 | 216 | 2 | 27840951 | ||
| Pubmed | 3.84e-05 | 2 | 216 | 2 | 19005184 | ||
| Pubmed | 3.84e-05 | 2 | 216 | 2 | 16361353 | ||
| Pubmed | 3.84e-05 | 2 | 216 | 2 | 17234954 | ||
| Pubmed | 3.84e-05 | 2 | 216 | 2 | 3931075 | ||
| Pubmed | 3.84e-05 | 2 | 216 | 2 | 15254585 | ||
| Pubmed | Heat-shock protein 70 genes and human longevity: a view from Denmark. | 3.84e-05 | 2 | 216 | 2 | 16804002 | |
| Interaction | CELF4 interactions | 5.74e-10 | 11 | 213 | 6 | int:CELF4 | |
| Interaction | SP4 interactions | 2.52e-08 | 46 | 213 | 8 | int:SP4 | |
| Interaction | ZNF683 interactions | 3.04e-08 | 10 | 213 | 5 | int:ZNF683 | |
| Interaction | NFYC interactions | SP2 SP4 LIN54 SREBF2 PRR20C PRR20D PRR20B PRR20E NFYA MGA PRR20A ARID2 MTR | 5.32e-08 | 177 | 213 | 13 | int:NFYC |
| Interaction | PRR34 interactions | 6.18e-08 | 21 | 213 | 6 | int:PRR34 | |
| Interaction | BEND2 interactions | 9.38e-08 | 12 | 213 | 5 | int:BEND2 | |
| Interaction | PTTG2 interactions | 2.33e-07 | 14 | 213 | 5 | int:PTTG2 | |
| Interaction | C3orf36 interactions | 2.51e-07 | 26 | 213 | 6 | int:C3orf36 | |
| Interaction | MBNL3 interactions | 5.00e-07 | 16 | 213 | 5 | int:MBNL3 | |
| Interaction | HYPK interactions | SP4 NAA10 FASN PRR20C PRR20D PRR20B PRR20E HSPA1A NAA11 PRR20A | 8.68e-07 | 125 | 213 | 10 | int:HYPK |
| Interaction | POGZ interactions | SP3 SP4 DMXL1 PRR20C PRR20D PRR20B PRR20E BANP NFYA MGA ASF1A NICN1 PRR20A TIPARP | 9.38e-07 | 265 | 213 | 14 | int:POGZ |
| Interaction | ZMYM2 interactions | ERCC4 SETX LIN54 SREBF2 SIX4 PTBP1 TRRAP HDAC3 DNAJC10 MGA HSPA1A SIN3A TIPARP P4HA1 | 1.22e-06 | 271 | 213 | 14 | int:ZMYM2 |
| Interaction | GTF2A1 interactions | 1.60e-06 | 104 | 213 | 9 | int:GTF2A1 | |
| Interaction | VEZF1 interactions | 1.74e-06 | 105 | 213 | 9 | int:VEZF1 | |
| Interaction | TPRX1 interactions | 2.23e-06 | 21 | 213 | 5 | int:TPRX1 | |
| Interaction | ZCCHC14 interactions | 2.30e-06 | 37 | 213 | 6 | int:ZCCHC14 | |
| Interaction | CDCA5 interactions | 2.45e-06 | 140 | 213 | 10 | int:CDCA5 | |
| Interaction | TBX6 interactions | 4.29e-06 | 41 | 213 | 6 | int:TBX6 | |
| Interaction | FAM222B interactions | 4.96e-06 | 42 | 213 | 6 | int:FAM222B | |
| Interaction | PRR20B interactions | 5.03e-06 | 90 | 213 | 8 | int:PRR20B | |
| Interaction | PRR20C interactions | 5.03e-06 | 90 | 213 | 8 | int:PRR20C | |
| Interaction | PRR20D interactions | 5.03e-06 | 90 | 213 | 8 | int:PRR20D | |
| Interaction | C10orf55 interactions | 5.53e-06 | 65 | 213 | 7 | int:C10orf55 | |
| Interaction | BICRAL interactions | 5.72e-06 | 43 | 213 | 6 | int:BICRAL | |
| Interaction | RBM23 interactions | 6.97e-06 | 94 | 213 | 8 | int:RBM23 | |
| Interaction | TBX3 interactions | 8.26e-06 | 69 | 213 | 7 | int:TBX3 | |
| Interaction | PRR20E interactions | 1.19e-05 | 101 | 213 | 8 | int:PRR20E | |
| Interaction | C1orf94 interactions | 1.37e-05 | 103 | 213 | 8 | int:C1orf94 | |
| Interaction | FOXP3 interactions | SP2 ORC3 HDAC3 FASN PRR20C PRR20D PRR20B PRR20E LPXN HSPA1A PRR20A ORC2 CSE1L SEC24C P4HA1 MPHOSPH10 | 1.54e-05 | 432 | 213 | 16 | int:FOXP3 |
| Interaction | PRR20A interactions | 2.08e-05 | 109 | 213 | 8 | int:PRR20A | |
| Interaction | ZNF385C interactions | 2.35e-05 | 33 | 213 | 5 | int:ZNF385C | |
| Interaction | DMRT3 interactions | 3.81e-05 | 87 | 213 | 7 | int:DMRT3 | |
| Interaction | HLX interactions | 4.16e-05 | 37 | 213 | 5 | int:HLX | |
| Interaction | EGLN3 interactions | USP34 PDE3B ERCC4 SETX VWA8 INPP5K NAA10 SRP54 PSMD7 SSR1 BIRC6 SORT1 LPIN1 HDAC3 RMI1 FASN BRCA2 RARS2 TMX3 MGA MRE11 DMXL2 RBM4 CAPN2 UBR4 DYRK1A GSC2 CSE1L MTR PARD3 | 4.31e-05 | 1296 | 213 | 30 | int:EGLN3 |
| Interaction | CABP2 interactions | 4.44e-05 | 61 | 213 | 6 | int:CABP2 | |
| Interaction | ATP6V1E1 interactions | 4.97e-05 | 123 | 213 | 8 | int:ATP6V1E1 | |
| Interaction | SLC5A1 interactions | 6.27e-05 | 8 | 213 | 3 | int:SLC5A1 | |
| Interaction | PSG8 interactions | 6.92e-05 | 41 | 213 | 5 | int:PSG8 | |
| Interaction | FOXRED2 interactions | 7.18e-05 | 96 | 213 | 7 | int:FOXRED2 | |
| Interaction | SMAP1 interactions | 7.58e-05 | 67 | 213 | 6 | int:SMAP1 | |
| Interaction | SAMD11 interactions | 8.74e-05 | 43 | 213 | 5 | int:SAMD11 | |
| Interaction | KLC1 interactions | ORC3 NAA10 PSMD7 SORT1 FASN KIF2B PRRC2C ANAPC2 HSPA1A DNAJC18 TIPARP | 8.95e-05 | 255 | 213 | 11 | int:KLC1 |
| Interaction | POU2F1 interactions | 1.05e-04 | 175 | 213 | 9 | int:POU2F1 | |
| Interaction | KCNJ11 interactions | 1.09e-04 | 24 | 213 | 4 | int:KCNJ11 | |
| Interaction | TRIM35 interactions | 1.12e-04 | 103 | 213 | 7 | int:TRIM35 | |
| Interaction | SIAH2 interactions | 1.19e-04 | 104 | 213 | 7 | int:SIAH2 | |
| Interaction | GLIS2 interactions | 1.34e-04 | 106 | 213 | 7 | int:GLIS2 | |
| Interaction | KRTAP19-1 interactions | 1.35e-04 | 47 | 213 | 5 | int:KRTAP19-1 | |
| Interaction | PDLIM5 interactions | STARD13 TES DCDC1 BIRC6 LPXN DMD HSPA1A DNAJC8 DYRK1A SIN3A TIPARP | 1.63e-04 | 273 | 213 | 11 | int:PDLIM5 |
| Interaction | ESRP1 interactions | 1.65e-04 | 77 | 213 | 6 | int:ESRP1 | |
| Interaction | HIVEP1 interactions | 1.67e-04 | 186 | 213 | 9 | int:HIVEP1 | |
| Interaction | OXER1 interactions | 1.81e-04 | 50 | 213 | 5 | int:OXER1 | |
| Interaction | POU6F2 interactions | 1.81e-04 | 148 | 213 | 8 | int:POU6F2 | |
| Interaction | BANP interactions | SP2 SP4 LIN54 PRR20C PRR20D PRR20B PRR20E BANP NFYA PRR20A TNXB | 1.85e-04 | 277 | 213 | 11 | int:BANP |
| Interaction | CDC25A interactions | 2.08e-04 | 151 | 213 | 8 | int:CDC25A | |
| Interaction | SOHLH1 interactions | 2.23e-04 | 115 | 213 | 7 | int:SOHLH1 | |
| Interaction | LGALS1 interactions | ITGA2 MET PTPRZ1 HSPA1A NPC1 FAT4 FRAS1 DYRK1A MUC16 GRID1 CELSR2 VCAN | 2.27e-04 | 332 | 213 | 12 | int:LGALS1 |
| Interaction | RIPPLY1 interactions | 2.85e-04 | 55 | 213 | 5 | int:RIPPLY1 | |
| Interaction | LASP1 interactions | TES PRR20C PRR20D PRR20B TINF2 PRR20E NFYA HSPA1A CHERP PRR20A | 3.11e-04 | 247 | 213 | 10 | int:LASP1 |
| Cytoband | 13q21.1 | 2.75e-09 | 13 | 216 | 5 | 13q21.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr13q21 | 2.40e-04 | 117 | 216 | 5 | chr13q21 | |
| GeneFamily | Zinc fingers C2H2-type|Sp transcription factors | 4.62e-05 | 9 | 151 | 3 | 755 | |
| GeneFamily | Cadherin related | 3.56e-04 | 17 | 151 | 3 | 24 | |
| GeneFamily | AAA ATPases|Origin recognition complex | 1.02e-03 | 6 | 151 | 2 | 960 | |
| Coexpression | NAKAYA_MONOCYTE_FLUMIST_AGE_18_50YO_7DY_UP | MON2 SETX TRRAP LYST DMXL1 HSPA1A HSPA1B ASF1A UBR4 CD1E MCTP1 PLXNC1 MICAL2 MTR TRAPPC10 | 8.77e-06 | 477 | 212 | 15 | M40930 |
| Coexpression | RIZKI_TUMOR_INVASIVENESS_3D_DN | ORC3 PTBP1 FASN IFI30 HSPA1A RAP2A RBM4 KLRK1 SEC24C CELSR2 PLXNC1 | 1.03e-05 | 262 | 212 | 11 | M11472 |
| Coexpression | TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP | 2.05e-05 | 69 | 212 | 6 | M10165 | |
| Coexpression | GSE2124_CTRL_VS_LYMPHOTOXIN_BETA_TREATED_MLN_UP | 3.45e-05 | 197 | 212 | 9 | M6191 | |
| Coexpression | GSE11864_UNTREATED_VS_CSF1_IFNG_PAM3CYS_IN_MAC_DN | 3.73e-05 | 199 | 212 | 9 | M3132 | |
| Coexpression | GSE17721_LPS_VS_PAM3CSK4_8H_BMDC_UP | 3.88e-05 | 200 | 212 | 9 | M3920 | |
| Coexpression | GSE17721_CPG_VS_GARDIQUIMOD_6H_BMDC_DN | 3.88e-05 | 200 | 212 | 9 | M3891 | |
| Coexpression | GSE39820_TGFBETA1_VS_TGFBETA3_IN_IL6_IL23A_TREATED_CD4_TCELL_DN | 3.88e-05 | 200 | 212 | 9 | M5629 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Medullary collecting duct_emap-28063_k-means-cluster#4_top-relative-expression-ranked_1000 | RGMB ERCC4 VWA8 BIRC6 AK3 PRRC2C SCAPER SHPRH NCEH1 CPLANE1 CTDSPL2 ARID2 VCAN SERAC1 | 2.82e-07 | 261 | 206 | 14 | gudmap_developingKidney_e15.5_Medullary collecting duct_1000_k4 |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_k-means-cluster#4_top-relative-expression-ranked_1000 | NAAA BIRC6 DMXL1 GREB1L SCAPER DMXL2 NAA11 LMBR1 MSH4 TIPARP | 5.90e-06 | 168 | 206 | 10 | gudmap_developingGonad_P2_ovary_1000_k4 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k-means-cluster#5_top-relative-expression-ranked_1000 | PDS5B RGMB SETX SRP54 CPLANE1 S100PBP CTDSPL2 VCAN TTC21B PRRC1 | 9.82e-06 | 178 | 206 | 10 | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k5_1000 |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_top-relative-expression-ranked_1000 | USP34 SP3 NAAA BIRC6 DMXL1 GREB1L TINF2 PRRC2C SCAPER CPLANE1 MGA DMXL2 NAA11 LMBR1 PIWIL2 MSH4 TIPARP TENM4 IQCA1 PLXNC1 PARD3 | 2.06e-05 | 770 | 206 | 21 | gudmap_developingGonad_P2_ovary_1000 |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#1_top-relative-expression-ranked_500 | 2.28e-05 | 59 | 206 | 6 | gudmap_developingGonad_e12.5_epididymis_k1_500 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_500 | SP3 SP4 NAAA PSMD7 BIRC6 DMXL1 GREB1L PRRC2C MGA PIWIL2 TIPARP TENM4 PLXNC1 MTR | 4.20e-05 | 403 | 206 | 14 | gudmap_developingGonad_e12.5_epididymis_500 |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#5_top-relative-expression-ranked_1000 | 6.18e-05 | 138 | 206 | 8 | gudmap_developingGonad_e12.5_epididymis_k5_1000 | |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_top-relative-expression-ranked_500 | SP3 BIRC6 DMXL1 GREB1L CPLANE1 DMXL2 NAA11 PIWIL2 TIPARP TENM4 IQCA1 PLXNC1 PARD3 | 8.99e-05 | 379 | 206 | 13 | gudmap_developingGonad_P2_ovary_500 |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#5_top-relative-expression-ranked_1000 | SP3 NAAA BIRC6 DMXL1 GREB1L SHPRH CPLANE1 DMXL2 TIPARP TENM4 | 9.74e-05 | 233 | 206 | 10 | gudmap_developingGonad_e12.5_ovary_k5_1000 |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_500 | SP3 BIRC6 DMXL1 GREB1L CPLANE1 MGA DMXL2 NAA11 PIWIL2 MSH4 TIPARP TENM4 PLXNC1 | 1.11e-04 | 387 | 206 | 13 | gudmap_developingGonad_e18.5_ovary_500 |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_k-means-cluster#3_top-relative-expression-ranked_500 | 1.20e-04 | 79 | 206 | 6 | gudmap_developingGonad_P2_ovary_500_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_k-means-cluster#5_top-relative-expression-ranked_1000 | PDS5B RGMB SETX SRP54 BIRC6 SHPRH CPLANE1 S100PBP DYRK1A PAIP1 VCAN SERAC1 PRRC1 | 1.43e-04 | 397 | 206 | 13 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_1000_k5 |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_1000 | PDE3B SETX LYST DMXL1 PHKA1 BRCA2 SCAPER PRMT9 CPLANE1 TRMT5 MGA WNK3 NOL8 S100PBP NPC1 MRE11 DMXL2 PIWIL2 ORC2 MTR | 1.51e-04 | 820 | 206 | 20 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_1000 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_1000 | USP34 SP3 SP4 NAAA BIRC6 DMXL1 GREB1L BRCA2 SCAPER SHPRH CPLANE1 MGA DMXL2 NAA11 PIWIL2 MSH4 TIPARP MTR SENP7 | 2.11e-04 | 776 | 206 | 19 | gudmap_developingGonad_e14.5_ ovary_1000 |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_1000 | USP34 SP3 NAAA BIRC6 DMXL1 GREB1L PRRC2C SCAPER C1R CPLANE1 MGA DMXL2 NAA11 PIWIL2 MSH4 TIPARP TENM4 IQCA1 PLXNC1 | 2.18e-04 | 778 | 206 | 19 | gudmap_developingGonad_e18.5_ovary_1000 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#4_top-relative-expression-ranked_1000 | 2.44e-04 | 127 | 206 | 7 | gudmap_developingGonad_e16.5_epididymis_1000_k4 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#4_top-relative-expression-ranked_1000 | 2.45e-04 | 90 | 206 | 6 | gudmap_developingGonad_P2_epididymis_1000_k4 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#5_top-relative-expression-ranked_500 | 2.60e-04 | 91 | 206 | 6 | gudmap_developingGonad_e12.5_ovary_k5_500 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | OBSCN FAT1 DMD USH2A FAT4 FRAS1 COL12A1 DNAH10 GRID1 PKHD1L1 TENM4 HYDIN | 9.92e-11 | 184 | 213 | 12 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | OBSCN FAT1 DMD USH2A FAT4 FRAS1 COL12A1 DNAH10 GRID1 PKHD1L1 TENM4 HYDIN | 9.92e-11 | 184 | 213 | 12 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | OBSCN FAT1 DMD USH2A FAT4 FRAS1 COL12A1 DNAH10 GRID1 PKHD1L1 TENM4 HYDIN | 9.92e-11 | 184 | 213 | 12 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | CFAP251 DCDC1 EXPH5 ITGA2 PTPRZ1 DLEC1 CPLANE1 DNAH10 IQCA1 STEAP3 CFAP57 HYDIN | 1.72e-10 | 193 | 213 | 12 | ea345d34440b25f65358a53dc72831998d1c3620 |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | SREBF2 ITGA2 MET NPC1 COL12A1 CAPN2 LAMA3 MICAL2 RASEF PARD3 | 2.62e-08 | 188 | 213 | 10 | 43a3a59f92ad93509d4166bd025aed0b1b39a008 |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal-Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | CDH26 OBSCN ITGA2 MET PTPRZ1 SORCS2 SEMA3F FRAS1 LAMA3 TENM4 | 4.49e-08 | 199 | 213 | 10 | 94a7867e800df352731796de8c24cba133c29622 |
| ToppCell | mild-Non-classical_Monocyte|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.70e-08 | 200 | 213 | 10 | 334bab6bf93d455f3526e817ea5785d8b6ee531c | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | CFAP251 OBSCN ABCC8 DLEC1 SEMA3F COL12A1 ATP6V0D1 MCTP1 IQCA1 | 5.57e-08 | 153 | 213 | 9 | b37a1ecad389d2848b8ca4d287823e8048207420 |
| ToppCell | droplet-Marrow-nan-3m-Hematologic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.46e-07 | 182 | 213 | 9 | e78ba2c5cae480c16a596ce7c3bf2d480becacf4 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.46e-07 | 182 | 213 | 9 | 1710eab3037a87609d21838be2d2d29c3bc36651 | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 2.82e-07 | 185 | 213 | 9 | 6baccb26f999145e51b91d94315bf8d4655bef31 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_goblet|COVID-19 / group, cell type (main and fine annotations) | 3.53e-07 | 190 | 213 | 9 | 51ca9ef4df3220487152fcf684147730637c7cc1 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.69e-07 | 191 | 213 | 9 | 7b386512284dfaa0e95358b28ee82632ee965e64 | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.69e-07 | 191 | 213 | 9 | 1c528f72c9ef3ef3a850b05e4a9715190832270c | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.69e-07 | 191 | 213 | 9 | e417bf491f8b8d7838a61f7f4f6b1740ba97aa3f | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.69e-07 | 191 | 213 | 9 | 9d31c8424d35bdc0c27188b68bfd0f731af3600b | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 4.03e-07 | 193 | 213 | 9 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.21e-07 | 194 | 213 | 9 | 97534c8bba895a7913665e03ae4e5c4a6ad71daf | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.21e-07 | 194 | 213 | 9 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.59e-07 | 196 | 213 | 9 | fa445f4240c521cf04eb2e2f79a5c55fda31209a | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.59e-07 | 196 | 213 | 9 | 802f61e78a9a1030a86c4a980c398a73cd4d1574 | |
| ToppCell | COVID-19-Epithelial|COVID-19 / Condition, Lineage and Cell class | 4.79e-07 | 197 | 213 | 9 | 18fd7344628a87d5c7ef5efb66e260a4136245bf | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 5.21e-07 | 199 | 213 | 9 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.23e-06 | 163 | 213 | 8 | 8e32b6431e1862572663aa6ddc4ea299c6acc8a6 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.23e-06 | 163 | 213 | 8 | bbc078761c5043af13d9a6fcf3145a3e300bae5e | |
| ToppCell | facs-Spleen-nan-3m-Lymphocytic-NK_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.28e-06 | 164 | 213 | 8 | a187bd5beca017ef657ef07c006e7f94ea3b911b | |
| ToppCell | droplet-Liver-nan-3m-Lymphocytic-NK_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.28e-06 | 164 | 213 | 8 | 950f87d9dacee45c9004a9bf894543de38f72ee5 | |
| ToppCell | droplet-Liver-nan-3m-Lymphocytic-NK/T|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.28e-06 | 164 | 213 | 8 | c33910a6d87580902e9e7bd27afe6ea63b5eff8d | |
| ToppCell | droplet-Liver-nan-3m-Lymphocytic|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.28e-06 | 164 | 213 | 8 | bf0d3ad9016a0b8011a2385bb92f0a4f5edad1d6 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.61e-06 | 169 | 213 | 8 | 14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f | |
| ToppCell | Adult-Epithelial-lung_goblet_cell-D231|Adult / Lineage, Cell type, age group and donor | 2.00e-06 | 174 | 213 | 8 | 7d2f802f493f19a068e097b2909a9000e2160266 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.00e-06 | 174 | 213 | 8 | 9c916af5eebd932f67dc9117e1d26ff194a2ff2c | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.00e-06 | 174 | 213 | 8 | bc71521f44a5fe013af42b06b5d1bd2446ecf3b5 | |
| ToppCell | CV-Severe-7|Severe / Virus stimulation, Condition and Cluster | 2.27e-06 | 177 | 213 | 8 | 82fdd6185b368f54f03de389427cbe3071d21a99 | |
| ToppCell | Control-Epithelial_cells-Airway_ciliated|Control / group, cell type (main and fine annotations) | 2.79e-06 | 182 | 213 | 8 | fb725d10d9ed25dfc6d5bb69cfef78513f7d3e8f | |
| ToppCell | COVID-19-Epithelial_cells-Airway_ciliated|COVID-19 / group, cell type (main and fine annotations) | 3.15e-06 | 185 | 213 | 8 | 18a40f0a338aa398d81384b5159fb80ce8a2020c | |
| ToppCell | Ciliated_cells-B-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 3.15e-06 | 185 | 213 | 8 | f012c243343e1d1956db19b34d062e9b13de2b2a | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.28e-06 | 186 | 213 | 8 | 310d16f4e5cffee3ea6d7635508c513a3b92131e | |
| ToppCell | droplet-Lung-18m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l39|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.41e-06 | 187 | 213 | 8 | 218c9b4f28499389c43005d9626af2ac01066027 | |
| ToppCell | droplet-Lung-18m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.41e-06 | 187 | 213 | 8 | c7ac4b328efc2ebb72f71154661914193ff402ca | |
| ToppCell | Adult-Endothelial-capillary_endothelial_cell_(Cap1)-D175|Adult / Lineage, Cell type, age group and donor | 3.41e-06 | 187 | 213 | 8 | f3548817f2fded5978137bb252cb628ac199e4f6 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.55e-06 | 188 | 213 | 8 | 0501a8aa850bd2e347020abd1cac4d8075738189 | |
| ToppCell | COVID-19-Epithelial_cells|COVID-19 / group, cell type (main and fine annotations) | 3.55e-06 | 188 | 213 | 8 | c9cdee6f8d42ee69f5fb335f25084603c511bd29 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.55e-06 | 188 | 213 | 8 | 997dcfc4f08738ab398d8abc15e4fd2fc6619862 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-alveolar_macrophage-alveolar_macrophage|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.69e-06 | 189 | 213 | 8 | 98f517af255ef234eefc3ed7e6c1d63331ab8af0 | |
| ToppCell | COVID-19-lung-Ciliated|lung / Disease (COVID-19 only), tissue and cell type | 3.69e-06 | 189 | 213 | 8 | 27329c4661aebabd19fac7fe5dca263fe99d76f3 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-alveolar_macrophage|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.69e-06 | 189 | 213 | 8 | f7e9b6e6a4de297b660a5b6c9a62f860c147185e | |
| ToppCell | IPF-Epithelial-Basal|IPF / Disease state, Lineage and Cell class | 3.84e-06 | 190 | 213 | 8 | ea19e9ce954f2dfde97388db9695325cd92ab88f | |
| ToppCell | Ciliated_cells-B|World / lung cells shred on cell class, cell subclass, sample id | 3.84e-06 | 190 | 213 | 8 | 7031fbedc13be1a00f6333ad6d51849c3739c2e6 | |
| ToppCell | Ciliated-cil-3|World / Class top | 4.15e-06 | 192 | 213 | 8 | 4989ebb8812b8af1870599acd932849122c05a29 | |
| ToppCell | IPF-Epithelial-Basal|World / Disease state, Lineage and Cell class | 4.15e-06 | 192 | 213 | 8 | 9b91e0b162e6f3ce86dd15cc33c2e745d069581f | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_alveolar-distal-epi_CTGF^high_distal_(3)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 4.15e-06 | 192 | 213 | 8 | 39804d9ddc67c1b41887752df2503389eae44a1a | |
| ToppCell | nucseq-Immune-Immune_Myeloid-pMON-pMON|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.48e-06 | 194 | 213 | 8 | e237384b02be460d44eeada3026a5691c66f6fc1 | |
| ToppCell | nucseq-Immune-Immune_Myeloid-pMON|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.48e-06 | 194 | 213 | 8 | 0bc83ae79873a5e473e6e1e3111924cd003986a1 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_alveolar-distal-epi_SFTPC^high_distal_(9)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.48e-06 | 194 | 213 | 8 | c47fc3f716ab091a39c20d7639ac783029589ee5 | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-MUC16+_ciliated|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 4.48e-06 | 194 | 213 | 8 | 756082a0f5953b52229bb60d40b84701cb6cb23d | |
| ToppCell | COVID-19-Epithelial-Ciliated_cells|COVID-19 / Condition, Lineage and Cell class | 4.48e-06 | 194 | 213 | 8 | 43be5fbd51dd58839cb03ca3ddd05a458e1ddb74 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_airway-epi_proximal_progenitor2_(4)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 4.65e-06 | 195 | 213 | 8 | d673f8844896d5c7b76a7bc7f6b88a039f1bc263 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_alveolar-distal-epi_CTGF^high_distal_(3)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.65e-06 | 195 | 213 | 8 | 62d369a8af2b76a2553bc8ff9cb89a133b060123 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.65e-06 | 195 | 213 | 8 | dd281a249854800f737dc22e0f375f66dfb5cf5f | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.65e-06 | 195 | 213 | 8 | edd4cd8402af81737b2074f9dce71cc6ab09be7e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.65e-06 | 195 | 213 | 8 | 49c99553629cdd83ee56a2e508d5bc8d34b8507b | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.65e-06 | 195 | 213 | 8 | dccc32fcf772e2504de7f663ef0a5bd8e23e92fc | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.65e-06 | 195 | 213 | 8 | 79dc031258579ea328181dda33710dd897f1064a | |
| ToppCell | COVID-19_Moderate-Non-classical_Monocyte|COVID-19_Moderate / disease group, cell group and cell class | 4.83e-06 | 196 | 213 | 8 | 256c557fa11414c9d2cbb1fcff33f482ee1c78ac | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.83e-06 | 196 | 213 | 8 | b07db4a53ab9be9aad6fae5e45f9547db829d096 | |
| ToppCell | Severe_COVID-19-Epithelial-Ciliated|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 4.83e-06 | 196 | 213 | 8 | 1cdef976a754c90d18b6149d367bd64e6e99b0a9 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Goblet|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.83e-06 | 196 | 213 | 8 | c366f980cc04abfe1c0c14746c11810c812a42c0 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-Ciliated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.83e-06 | 196 | 213 | 8 | 69f5081e06d84ec1d9695762df801a9d0df1984b | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-Ciliated|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.83e-06 | 196 | 213 | 8 | 686a5a0ddb00929842c1c98445c59edfcc9a8a04 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-Ciliated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.83e-06 | 196 | 213 | 8 | 67aefc480714e4b8c9ae53c036efdc07ec6f94af | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-Ciliated|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.83e-06 | 196 | 213 | 8 | ca56311edc6788e032e7635fa69b1e07035202b5 | |
| ToppCell | Bronchus_Control_(B.)-Epithelial-TX-AT1|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 5.01e-06 | 197 | 213 | 8 | f7ef62d78336812573148f8bfce401877ec4e29c | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.01e-06 | 197 | 213 | 8 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | ASK452-Epithelial-Type_1|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq | 5.01e-06 | 197 | 213 | 8 | dc0a6dca4af6b216357b06f67203274f8b2a8bb0 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 5.01e-06 | 197 | 213 | 8 | 3d13a4f2e86422900ee2194e8a1fd1cf9750d5d3 | |
| ToppCell | Healthy-Non-classical_Monocyte|Healthy / disease group, cell group and cell class | 5.20e-06 | 198 | 213 | 8 | 394e5fa8998c46c6f7cd57b53f347d2029c75ae1 | |
| ToppCell | Healthy-Non-classical_Monocyte|World / disease group, cell group and cell class | 5.20e-06 | 198 | 213 | 8 | 4fd27a9fb3758c94ed9f0a726296e92b0625da44 | |
| ToppCell | Healthy_Control-Myeloid-Macrophages-FCN1+SPP1+|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 5.20e-06 | 198 | 213 | 8 | aa90326b82e21de37af5642df6a70a8b21af7f04 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.20e-06 | 198 | 213 | 8 | 5374b0e98d669f36a0571d3c006c7bd5e3c8e87f | |
| ToppCell | distal-Epithelial-Ciliated-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.40e-06 | 199 | 213 | 8 | 6ce0df4a6f4d9353919e26ffab97c9ec89911da6 | |
| ToppCell | COVID-19-kidney-Fibroblast-1|kidney / Disease (COVID-19 only), tissue and cell type | 5.40e-06 | 199 | 213 | 8 | 9503646ff1ad248181146ce767e9d12e882ec3bd | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.40e-06 | 199 | 213 | 8 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | distal-Epithelial-Ciliated|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.40e-06 | 199 | 213 | 8 | 18ca031cfe702afb9bf94e03c0f3680c38e7599e | |
| ToppCell | COVID-19|World / group, cell type (main and fine annotations) | 5.60e-06 | 200 | 213 | 8 | ac38a468559c33ee00152735ce6e408f3f48df84 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-NMBR-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 5.60e-06 | 200 | 213 | 8 | d416a7be1a4e6232fb58a9687774da24821f1fdd | |
| ToppCell | mild-Non-classical_Monocyte|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.60e-06 | 200 | 213 | 8 | 692b48da9fd56bafcb3c8b33b0fe369160881c45 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|Control_saline / Treatment groups by lineage, cell group, cell type | 5.60e-06 | 200 | 213 | 8 | a799fc7bb83ad0524362cb5010df949741fb7bf3 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-NMBR|Neuronal / cells hierarchy compared to all cells using T-Statistic | 5.60e-06 | 200 | 213 | 8 | 862db57d043bdf3cb059fbfc8b29bc1eafdf64ec | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-NMBR--L1|Neuronal / cells hierarchy compared to all cells using T-Statistic | 5.60e-06 | 200 | 213 | 8 | a91345f268f13170c27309333603eb82400c9947 | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Monocytic-Monocyte_CD16|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.60e-06 | 200 | 213 | 8 | fc061de0db2e8b5ca47f5e2a1e861018e7f1b582 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_mucous|COVID-19 / group, cell type (main and fine annotations) | 8.37e-06 | 151 | 213 | 7 | 8216462e723fec2797387929dde095370947e10a | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.52e-06 | 154 | 213 | 7 | 1e32969bee810adaf2d560f0824a16227df513d8 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Neural-neural_cell-Schwann_Cell_/_Neural|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.22e-05 | 160 | 213 | 7 | 14dfa519e68bab4bce890ddb66fa7763f18d9f19 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-05 | 160 | 213 | 7 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Neural-neural_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.22e-05 | 160 | 213 | 7 | 839bbdfd4e4c7b48260c8bfb7670378634405e1d | |
| ToppCell | PND07-28-samps-Myeloid-Macrophage-macrophage-B|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 1.22e-05 | 160 | 213 | 7 | 694bf1f1952bd8ab444819f533da24fa2b73f701 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-05 | 160 | 213 | 7 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Neural|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.22e-05 | 160 | 213 | 7 | 5b7789d4668ed7732babedc32d812233b430e0bd | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Neural-neural_cell-Schwann_Cell_/_Neural-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.22e-05 | 160 | 213 | 7 | bba1486faaad5299e10f4fe17c6d149c28dc2560 | |
| Disease | obsolete aging, cognition | 5.29e-08 | 15 | 213 | 5 | EFO_0003925, GO_0007568 | |
| Disease | telomere length | RMI1 PRR20C PRR20D PRR20B TINF2 PRR20E BANP CPLANE1 HSPA1A PRR20A MCTP1 MICAL2 CFAP57 SENP7 | 7.56e-08 | 313 | 213 | 14 | EFO_0004505 |
| Disease | mosaic loss of chromosome Y measurement | 1.88e-06 | 80 | 213 | 7 | EFO_0007783 | |
| Disease | Tinnitus, wellbeing measurement | 6.40e-06 | 96 | 213 | 7 | EFO_0007869, HP_0000360 | |
| Disease | t-tau:beta-amyloid 1-42 ratio measurement | 8.35e-06 | 66 | 213 | 6 | EFO_0007708 | |
| Disease | melanoma | 1.41e-05 | 248 | 213 | 10 | C0025202 | |
| Disease | complement C4b measurement | 2.96e-05 | 25 | 213 | 4 | EFO_0008092 | |
| Disease | Nail Diseases | 5.19e-05 | 2 | 213 | 2 | C0027339 | |
| Disease | Ophthalmoparesis | 5.19e-05 | 2 | 213 | 2 | C0751401 | |
| Disease | Internal Ophthalmoplegia | 5.19e-05 | 2 | 213 | 2 | C0339693 | |
| Disease | Ophthalmoplegia | 5.19e-05 | 2 | 213 | 2 | C0029089 | |
| Disease | Ogden syndrome (implicated_via_orthology) | 5.19e-05 | 2 | 213 | 2 | DOID:0050781 (implicated_via_orthology) | |
| Disease | External Ophthalmoplegia | 5.19e-05 | 2 | 213 | 2 | C0162292 | |
| Disease | Malignant neoplasm of ovary | 6.44e-05 | 137 | 213 | 7 | C1140680 | |
| Disease | Schizophrenia | CYP1A2 SP4 NPSR1 SREBF2 TRRAP MET HDAC3 PTPRZ1 HSPA1A HSPA1B WNK3 DRD4 CASP4 GRID1 PTPN21 TENM4 MTR TNXB | 8.07e-05 | 883 | 213 | 18 | C0036341 |
| Disease | endometrial cancer (is_implicated_in) | 1.30e-04 | 36 | 213 | 4 | DOID:1380 (is_implicated_in) | |
| Disease | keratoconjunctivitis (is_marker_for) | 1.55e-04 | 3 | 213 | 2 | DOID:9368 (is_marker_for) | |
| Disease | Disorder of eye | 1.63e-04 | 212 | 213 | 8 | C0015397 | |
| Disease | sortilin measurement | 3.08e-04 | 4 | 213 | 2 | EFO_0600000 | |
| Disease | ovarian neoplasm | 4.40e-04 | 134 | 213 | 6 | C0919267 | |
| Disease | intermediate coronary syndrome (is_implicated_in) | 5.11e-04 | 5 | 213 | 2 | DOID:8805 (is_implicated_in) | |
| Disease | graft-versus-host disease (biomarker_via_orthology) | 5.11e-04 | 5 | 213 | 2 | DOID:0081267 (biomarker_via_orthology) | |
| Disease | response to trauma exposure, post-traumatic stress disorder symptom measurement | 5.11e-04 | 5 | 213 | 2 | EFO_0008483, EFO_0008535 | |
| Disease | Squamous cell carcinoma of esophagus | 6.40e-04 | 95 | 213 | 5 | C0279626 | |
| Disease | Sjogren's syndrome (is_marker_for) | 6.71e-04 | 24 | 213 | 3 | DOID:12894 (is_marker_for) | |
| Disease | breast cancer (implicated_via_orthology) | 7.59e-04 | 25 | 213 | 3 | DOID:1612 (implicated_via_orthology) | |
| Disease | brain edema (implicated_via_orthology) | 7.63e-04 | 6 | 213 | 2 | DOID:4724 (implicated_via_orthology) | |
| Disease | alpha fetoprotein measurement | 8.08e-04 | 100 | 213 | 5 | EFO_0010583 | |
| Disease | Vomiting | 1.06e-03 | 7 | 213 | 2 | C0042963 | |
| Disease | Cerebral ventriculomegaly | 1.06e-03 | 7 | 213 | 2 | C1531647 | |
| Disease | Hydrocephalus Ex-Vacuo | 1.06e-03 | 7 | 213 | 2 | C0270720 | |
| Disease | newborn respiratory distress syndrome (is_implicated_in) | 1.06e-03 | 7 | 213 | 2 | DOID:12716 (is_implicated_in) | |
| Disease | Communicating Hydrocephalus | 1.06e-03 | 7 | 213 | 2 | C0009451 | |
| Disease | Fetal Cerebral Ventriculomegaly | 1.06e-03 | 7 | 213 | 2 | C2936718 | |
| Disease | Post-Traumatic Hydrocephalus | 1.06e-03 | 7 | 213 | 2 | C0477432 | |
| Disease | vascular dementia (is_implicated_in) | 1.06e-03 | 7 | 213 | 2 | DOID:8725 (is_implicated_in) | |
| Disease | Obstructive Hydrocephalus | 1.06e-03 | 7 | 213 | 2 | C0549423 | |
| Disease | Alzheimer disease, polygenic risk score | SREBF2 FSIP2 CLPTM1 LPXN SCAPER SEMA3F FRAS1 PCDHGB2 PCDHGA1 PAIP1 LY75 HYDIN | 1.21e-03 | 586 | 213 | 12 | EFO_0030082, MONDO_0004975 |
| Disease | intellectual disability (is_implicated_in) | 1.30e-03 | 30 | 213 | 3 | DOID:1059 (is_implicated_in) | |
| Disease | Unilateral agenesis of kidney | 1.41e-03 | 8 | 213 | 2 | C0266294 | |
| Disease | Congenital Hydrocephalus | 1.41e-03 | 8 | 213 | 2 | C0020256 | |
| Disease | Aqueductal Stenosis | 1.41e-03 | 8 | 213 | 2 | C2936786 | |
| Disease | Microcephaly | 1.42e-03 | 67 | 213 | 4 | C0025958 | |
| Disease | Beta blocking agent use measurement | 1.45e-03 | 114 | 213 | 5 | EFO_0009929 | |
| Disease | Polydactyly | 1.63e-03 | 117 | 213 | 5 | C0152427 | |
| Disease | Hydrocephalus | 1.81e-03 | 9 | 213 | 2 | C0020255 | |
| Disease | Major depression, single episode | 1.81e-03 | 9 | 213 | 2 | C0024517 | |
| Disease | waist-hip ratio, metabolic syndrome | 1.81e-03 | 9 | 213 | 2 | EFO_0000195, EFO_0004343 | |
| Disease | Liver diseases | 1.85e-03 | 72 | 213 | 4 | C0023895 | |
| Disease | Liver Dysfunction | 1.85e-03 | 72 | 213 | 4 | C0086565 | |
| Disease | Colorectal Carcinoma | CYP1A2 OBSCN BRINP1 PGM1 LPIN1 PROM1 FAT1 NLGN4X ABCC8 DMD GRID1 CSE1L NEURL1 | 1.88e-03 | 702 | 213 | 13 | C0009402 |
| Disease | cardiovascular disease | USP34 CYP1A2 DCDC1 LIN54 KCNK3 PCDH18 NPC1 GRID1 C3P1 CELSR2 | 1.90e-03 | 457 | 213 | 10 | EFO_0000319 |
| Disease | urate measurement, bone density | PDE3B ERCC4 LIN54 FSIP2 KIRREL3 USH2A FRAS1 GRID1 TIPARP CCER1 PLXNC1 TNXB | 1.92e-03 | 619 | 213 | 12 | EFO_0003923, EFO_0004531 |
| Disease | smoking status measurement | MON2 ERCC4 SREBF2 BRINP1 BIRC6 INPP4B SH3YL1 MET RMI1 KIF2B DLEC1 USH2A SEMA3F NAA11 WDR27 GRID1 TENM4 MCTP1 | 1.98e-03 | 1160 | 213 | 18 | EFO_0006527 |
| Disease | coffee consumption measurement | 2.14e-03 | 182 | 213 | 6 | EFO_0006781 | |
| Disease | attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement | ERCC4 DCDC1 CDH23 BRINP1 BIRC6 INPP4B MET RMI1 DNAJC10 KIF2B USH2A WDR27 TENM4 MCTP1 | 2.16e-03 | 801 | 213 | 14 | EFO_0003888, EFO_0007052, MONDO_0002491 |
| Disease | theophylline measurement | 2.25e-03 | 10 | 213 | 2 | EFO_0021180 | |
| Disease | 1,7-dimethylurate measurement | 2.25e-03 | 10 | 213 | 2 | EFO_0021512 | |
| Disease | dry eye syndrome (is_marker_for) | 2.25e-03 | 10 | 213 | 2 | DOID:10140 (is_marker_for) | |
| Disease | Malignant Neoplasms | 2.41e-03 | 128 | 213 | 5 | C0006826 | |
| Disease | Glioblastoma | 2.60e-03 | 79 | 213 | 4 | C0017636 | |
| Disease | bitter alcoholic beverage consumption measurement | 2.85e-03 | 133 | 213 | 5 | EFO_0010092 | |
| Disease | Giant Cell Glioblastoma | 3.25e-03 | 84 | 213 | 4 | C0334588 | |
| Disease | complement C1q tumor necrosis factor-related protein 1 measurement | 3.26e-03 | 12 | 213 | 2 | EFO_0801493 | |
| Disease | granulins measurement | 3.26e-03 | 12 | 213 | 2 | EFO_0008141 | |
| Disease | apolipoprotein B measurement | SP4 PDE3B ACADVL SORT1 BRCA2 CLPTM1 KCNK3 SORCS2 DNAH10 RBM4 CELSR2 HYDIN | 3.35e-03 | 663 | 213 | 12 | EFO_0004615 |
| Disease | autistic disorder (is_implicated_in) | 3.46e-03 | 42 | 213 | 3 | DOID:12849 (is_implicated_in) | |
| Disease | platelet component distribution width | PDS5B CYP1A2 LIN54 ITGA2 PTBP1 INPP4B PRRC2C DLEC1 NPC1 SIGLEC14 SIN3A ERI1 TNXB | 3.50e-03 | 755 | 213 | 13 | EFO_0007984 |
| Disease | bipolar I disorder | 3.66e-03 | 141 | 213 | 5 | EFO_0009963 | |
| Disease | psoriatic arthritis | 3.68e-03 | 87 | 213 | 4 | EFO_0003778 | |
| Disease | dilated cardiomyopathy (is_implicated_in) | 3.70e-03 | 43 | 213 | 3 | DOID:12930 (is_implicated_in) | |
| Disease | toxic shock syndrome (is_implicated_in) | 3.84e-03 | 13 | 213 | 2 | DOID:14115 (is_implicated_in) | |
| Disease | DEAFNESS, AUTOSOMAL RECESSIVE (disorder) | 3.84e-03 | 13 | 213 | 2 | C1846647 | |
| Disease | amyotrophic lateral sclerosis (biomarker_via_orthology) | 3.84e-03 | 13 | 213 | 2 | DOID:332 (biomarker_via_orthology) | |
| Disease | Familial dilated cardiomyopathy | 3.95e-03 | 44 | 213 | 3 | C0340427 | |
| Disease | amino acid measurement | SETX DCDC1 NPSR1 ITGA2 KIF2B SHPRH TXNDC16 FAT4 ASPG DNAJC18 TENM4 VCAN | 3.99e-03 | 678 | 213 | 12 | EFO_0005134 |
| Disease | Colorectal Neoplasms | 4.14e-03 | 277 | 213 | 7 | C0009404 | |
| Disease | visual epilepsy (biomarker_via_orthology) | 4.16e-03 | 90 | 213 | 4 | DOID:11832 (biomarker_via_orthology) | |
| Disease | emphysema imaging measurement | 4.24e-03 | 146 | 213 | 5 | EFO_0007626 | |
| Disease | Pneumoconiosis | 4.46e-03 | 14 | 213 | 2 | C0032273 | |
| Disease | Bagassosis | 4.46e-03 | 14 | 213 | 2 | C0004681 | |
| Disease | thalamus volume change measurement | 4.46e-03 | 14 | 213 | 2 | EFO_0021496 | |
| Disease | phoneme awareness | 4.46e-03 | 14 | 213 | 2 | EFO_0021812 | |
| Disease | Hereditary Breast and Ovarian Cancer Syndrome | 4.46e-03 | 14 | 213 | 2 | C0677776 | |
| Disease | serum alanine aminotransferase measurement | PDS5B EXPH5 SSR1 PTBP1 MET IFI30 NPC1 COL12A1 DYRK1A TENM4 CELSR2 P4HA1 RASEF SENP7 | 4.46e-03 | 869 | 213 | 14 | EFO_0004735 |
| Disease | red blood cell density measurement | STARD13 SP3 SP4 DCDC1 LIN54 SSR1 SORCS2 TBX6 SHLD2 DNAH10 RGS14 ARID2 LY75 SENP7 | 4.97e-03 | 880 | 213 | 14 | EFO_0007978 |
| Disease | autism spectrum disorder (implicated_via_orthology) | 5.02e-03 | 152 | 213 | 5 | DOID:0060041 (implicated_via_orthology) | |
| Disease | Cardiomyopathy, Dilated | 5.05e-03 | 48 | 213 | 3 | C0007193 | |
| Disease | 1,3,7-trimethylurate measurement | 5.12e-03 | 15 | 213 | 2 | EFO_0021172 | |
| Disease | quinate measurement | 5.12e-03 | 15 | 213 | 2 | EFO_0021167 | |
| Disease | ocular hypertension, response to triamcinolone acetonide | 5.35e-03 | 49 | 213 | 3 | EFO_0006954, EFO_1001069 | |
| Disease | Tourette syndrome | 5.66e-03 | 50 | 213 | 3 | EFO_0004895 | |
| Disease | non-high density lipoprotein cholesterol measurement | USP34 PDE3B PTBP1 ATAT1 BRCA2 KCNK3 SORCS2 NPC1 DNAH10 CSE1L CELSR2 HYDIN | 5.91e-03 | 713 | 213 | 12 | EFO_0005689 |
| Disease | status epilepticus (biomarker_via_orthology) | 6.03e-03 | 100 | 213 | 4 | DOID:1824 (biomarker_via_orthology) | |
| Disease | QRS duration | 6.12e-03 | 298 | 213 | 7 | EFO_0005055 | |
| Disease | Atrial Fibrillation | 6.22e-03 | 160 | 213 | 5 | C0004238 | |
| Disease | Endometrioma | 6.38e-03 | 161 | 213 | 5 | C0269102 | |
| Disease | Endometriosis | 6.38e-03 | 161 | 213 | 5 | C0014175 | |
| Disease | Glycogen storage disease | 6.57e-03 | 17 | 213 | 2 | cv:C0017919 | |
| Disease | Astrocytosis | 6.57e-03 | 17 | 213 | 2 | C3887640 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SVFAPQEQEYQQALL | 31 | Q9H313 | |
| EPQNAQLFYNITLAF | 281 | Q7Z4L5 | |
| ILQNVTAEQPYFIEA | 676 | Q7Z4L5 | |
| SPLQGSDIQVQYVQL | 471 | Q8N9N5 | |
| QQYVRPEINTQLSDF | 171 | Q8IV48 | |
| QSNTVQNILEPFYVL | 571 | Q6P2P2 | |
| PVQAVILLYFQDQAS | 661 | Q9UJX6 | |
| SPAYVADLVLANQQI | 2976 | Q9NR09 | |
| IIIDNSPQAFAYQLS | 401 | Q05D32 | |
| FFINEINIPSINYTL | 171 | Q7RTX7 | |
| VNFTEVEQINNTLYP | 2271 | P13611 | |
| QIIFPQYLQEKFVQS | 231 | O60477 | |
| PDVLLYDTIFQIFNN | 226 | P49662 | |
| VNNVVVLDNPSPFYN | 6 | Q9Y294 | |
| TFQQYTQKLFIPNIT | 276 | P31997 | |
| QSFYNLVVQVHDLPQ | 2011 | Q6V0I7 | |
| VVIVSQPAQQGQTYA | 926 | Q68CP9 | |
| LYQNTNIVFLDDPFS | 826 | O60706 | |
| VSQPEDQYSELFQIQ | 1461 | Q8TDJ6 | |
| PVLGNFEILFNNYVT | 1021 | Q9HCU4 | |
| QSTRNYPQVNVINFT | 146 | P11532 | |
| QQVSALSYSDQIQQP | 51 | Q13627 | |
| LSYSDQIQQPLTNQV | 56 | Q13627 | |
| DEFTIIQNLQPQYQF | 316 | P00736 | |
| SQNLYSNVFKPADVV | 251 | Q16581 | |
| INDEAPVFTQQQYSR | 1201 | Q9H251 | |
| QDQAFITPANLVFVY | 226 | Q13319 | |
| QVLSASNPTVFNFYN | 1801 | Q9Y485 | |
| LQETLYGFVQNPSLA | 246 | Q8TC90 | |
| PQRNQVFIFQTLATF | 31 | Q86XH1 | |
| VQNYVTFNPTNNKEL | 396 | Q8TBY9 | |
| QDFYQEVANPLLTAV | 451 | Q14624 | |
| AVIAANIFSIPYFQQ | 311 | P36871 | |
| VYSLVNQQSFQDIKP | 81 | P10114 | |
| VYSLVNQQSFQDIKP | 81 | P61225 | |
| VYSLVNQQSFQDIKP | 81 | Q9Y3L5 | |
| VYNYAEQTLSQLPQV | 241 | Q9BWF3 | |
| AQAIEPYITNFFNQV | 226 | Q9NTI5 | |
| EQVSTLYQNINLVEP | 146 | Q8IZ41 | |
| FDPYNQVVVSVANVI | 186 | P05177 | |
| GEPEYSQVIQINLNS | 426 | P48200 | |
| PGIFQENSFTIQYIL | 186 | Q7Z3E1 | |
| LQPAESVYRLNFTQQ | 46 | P47874 | |
| DNSPAFEQQSYIIQL | 241 | Q9HCL0 | |
| FEQQSYIIQLLENSP | 246 | Q9HCL0 | |
| TVDPVTNQNLQYFLD | 146 | Q16654 | |
| INDNPPVFAQQSYAV | 2276 | Q14517 | |
| PFTLNFTITNLQYEE | 12231 | Q8WXI7 | |
| PFTLNFTITNLQYEE | 12856 | Q8WXI7 | |
| GPQLQAEQEQFSSYV | 461 | M0R2J8 | |
| QLINIQAFSTQAPYV | 1206 | Q86XX4 | |
| AVLPAQYVTQLQQSS | 471 | Q6MZP7 | |
| FLSRVPSDVQVVQYQ | 966 | Q6DN14 | |
| NTLLNLDPENVVFYV | 2526 | Q16787 | |
| NIQITQLKIDYNPFA | 241 | Q8IWI9 | |
| FIQSTFDNPLQVVAY | 261 | Q9BQP7 | |
| QERFYASVIIQNLPA | 306 | Q6W5P4 | |
| QYVIPEVCLFFQNQL | 166 | Q86U10 | |
| LFQILSVVPVYNNFT | 321 | Q02083 | |
| DQALQTQPQYVAFSF | 211 | O14649 | |
| TPQFIDQQQFYLALD | 521 | P46020 | |
| SIISNEILLSFPQNY | 81 | Q8WVP7 | |
| IVRIDTQNNPVYQVS | 146 | Q96MR6 | |
| VYPVLFNVGINEQQT | 741 | O15327 | |
| QLILSPLNVFVSDNY | 856 | Q2LD37 | |
| YQIDTVINLNVPFEV | 106 | Q9UIJ7 | |
| HVQVPFQQLNQLAAY | 131 | P47710 | |
| PYQNNILFQENIIVS | 2376 | Q5CZC0 | |
| QIFTTYSDNQPGVLI | 426 | P0DMV9 | |
| NQALQVFYIKSIEPQ | 656 | O60486 | |
| ENPLNIFYIAVIVQD | 111 | Q9Y5G2 | |
| AFLVATNAPQAVLYN | 831 | Q13370 | |
| LYSNTLNFQISEVEP | 121 | P41227 | |
| ALDFNTPSYQQNVNT | 226 | Q6PIU2 | |
| SLFNQEVQIPLTESY | 81 | P26718 | |
| QAVSYQQFVDNPAII | 486 | Q14693 | |
| ITDPYQQAFLSVQAL | 1141 | O60449 | |
| PILQYFQNAVSETIN | 86 | O00566 | |
| YTQNTNLLIESPQVE | 1271 | Q8NEV8 | |
| LPAQLVYTTNIQELN | 56 | O60711 | |
| SGEVFLNQIYTQLPI | 506 | P98088 | |
| LNQIYTQLPISAANV | 511 | P98088 | |
| VVQLISNEILPYANF | 1526 | Q7Z3U7 | |
| YIQPQKRQTTFESQD | 641 | Q76FK4 | |
| IIYGNETELQIPSFN | 1046 | P23471 | |
| QVVPSLYSNDELFQT | 1281 | P23471 | |
| QFLVSLPLNVGSYQD | 556 | Q5TGP6 | |
| VLQVSSFPYTLQTQQ | 821 | Q9C091 | |
| TVQLTAAAEINTYNP | 1091 | P17301 | |
| VNSALNPVIYTVFNA | 391 | P21917 | |
| FQPVINQVVDFYQPT | 236 | O15379 | |
| NQVVDFYQPTCIVLQ | 241 | O15379 | |
| NISNQDIRFQAVPYS | 41 | Q8N8X9 | |
| VELIYQQATSIPNFS | 201 | Q9H074 | |
| VVFYVPSVSQLQQEI | 101 | Q16825 | |
| PSVSQLQQEITRYQY | 106 | Q16825 | |
| AVLQVIQTPQGTYVQ | 196 | P86480 | |
| NNATALVITFPVNNY | 556 | O15118 | |
| ELQNQEVQDGYPVSF | 5131 | Q5VST9 | |
| ISNLTIQRQYFPNDE | 111 | P13674 | |
| AVLQVIQTPQGTYVQ | 196 | P86496 | |
| AVLQVIQTPQGTYVQ | 196 | P86481 | |
| FTLIDSQAQYPVVNT | 36 | Q8NFZ3 | |
| PLDFEVIQSYTINIQ | 306 | Q9Y5E9 | |
| QIVQASAGQFQLEYP | 106 | P15812 | |
| TPNQTNIINFYEVEL | 4206 | Q4G0P3 | |
| LEALFVQNQYPDVST | 141 | O15499 | |
| PYFITLGTELVQQQE | 306 | P17658 | |
| VSPYLSQFQQDKQQL | 2151 | P51587 | |
| QQLPVSDEILFQIYQ | 3036 | P51587 | |
| QIQQTSYSIVLEPQG | 126 | Q6ZMU1 | |
| INEYSSVVQPVQLAF | 296 | Q8IWX8 | |
| ITYRPQQFTFQDSNN | 371 | Q9H799 | |
| ENTLVFENLNPNTIY | 1706 | Q99715 | |
| FENLNPNTIYEVSIT | 1711 | Q99715 | |
| SAYRIQKNAFVNQPT | 2551 | Q99715 | |
| SLNTDNYLVQAVPFN | 2471 | Q9UFH2 | |
| VTLVPYGNAQEQNVS | 96 | P13284 | |
| DNLNQVYIDISNIPT | 391 | Q9BT40 | |
| SKAQNQFTVYEVLNP | 246 | Q8IYJ1 | |
| VNEELPSINTYFPQN | 601 | Q5VWK5 | |
| FLNIKQVADQPYVQQ | 611 | Q9NSG2 | |
| QVADQPYVQQTFSLL | 616 | Q9NSG2 | |
| ENRPFAQQLSNVYFT | 6 | Q8WWX0 | |
| SYIQLDFSPVVQQQK | 216 | Q8NFQ5 | |
| PVNFIQSSQQYQVTS | 3556 | Q99698 | |
| FTLFVYEQLQEPQVT | 146 | Q9HBG7 | |
| YNLETTVPQVNNFVI | 171 | Q5SQI0 | |
| NTPNSQVLYFLISQT | 196 | Q8IXH8 | |
| SSYFNLNPFEVLQID | 51 | O75937 | |
| ISRETQNLQVPYFVD | 266 | Q9H819 | |
| TYSIKVIEANNPFQA | 61 | Q9ULK0 | |
| QVYSFSQQPQDQVVV | 46 | Q8IZU9 | |
| QIFTTYSDNQPGVLI | 426 | P0DMV8 | |
| QAYPTTVVFNQSNIH | 521 | Q8IXB1 | |
| SAEYNVNNLVSPVLF | 731 | P49327 | |
| LARVVPLNQSFQENY | 121 | P17655 | |
| NLLLEYTNQTTQVVP | 1611 | Q9Y238 | |
| INFYNDISLNPQIIE | 956 | Q8IVF4 | |
| NQYVDVATLSVVPQL | 701 | P53992 | |
| PTFSQSNLEQQKQLY | 311 | Q96BU1 | |
| YFTVNHPDNQVIVQS | 1276 | Q9BY12 | |
| QNISESNPAYEVFQT | 181 | Q68D06 | |
| FTLIDSQAQYPVVNT | 36 | Q8N0W4 | |
| SLQAQVVLSFQAYPT | 191 | Q8NAC3 | |
| NELVYQFTAQPLVES | 276 | Q8N4N8 | |
| TTPENINKNFEQYTL | 451 | O94851 | |
| NNVSAFQPYQATSEI | 111 | Q8TEW0 | |
| QTAEGQTIVYQPVNA | 161 | P23511 | |
| QTIVYQPVNADGTIL | 166 | P23511 | |
| AFTQAQYHINVPENV | 241 | Q9Y5H4 | |
| PQQFQYTLDNNVLTL | 41 | O14832 | |
| LTEALQNNVTPYVVS | 121 | Q9UBD5 | |
| QNNVTPYVVSLQAKD | 126 | Q9UBD5 | |
| PSFSAELKQLNQQYE | 281 | Q13416 | |
| YQLPNFTAETPIQNV | 41 | P08581 | |
| SNPLQHLFEVYVQVN | 196 | Q5T160 | |
| GLVPFTNYTVQVNIS | 2401 | O75445 | |
| DNNYLSVQVTNVPVV | 191 | Q6NW40 | |
| FQYEVSAVHNLQPTQ | 276 | Q9NYK5 | |
| YEDFPQTVSQQSQAQ | 876 | Q9BQF6 | |
| QLPSVGQEQFYSILA | 341 | Q99523 | |
| AQLYEDSQFPINIVA | 76 | Q9Y3M8 | |
| GSVQYQVIPQLQTVE | 161 | Q02446 | |
| NFQVLNFVETLPTYI | 581 | Q96JX3 | |
| FQIPASVLYKNQTRN | 466 | Q32P41 | |
| NAIDPEVQRVTYNNF | 366 | Q9UGI8 | |
| QFYIQNFTALPLNTV | 131 | P43307 | |
| LQVANAIQPDNIVYV | 206 | P61011 | |
| QTQDVRNPVIYAVFT | 346 | Q13275 | |
| PLVIDYFQNQTDSNG | 121 | P07988 | |
| FIQYLDEPTVNTQIF | 376 | Q96KG9 | |
| ALQINSLVDVSQPAY | 86 | Q9H9A7 | |
| ISTNLYLAAPQNFVT | 856 | Q8TC59 | |
| PINHQIIYQLQDVFN | 221 | P51665 | |
| YPSTQQYNDVVNALL | 191 | Q8N6K7 | |
| IQQAQAAPDQFVLYF | 326 | Q9Y289 | |
| AVLQVIQTPQGTYVQ | 196 | P86479 | |
| NNDILSITQPDVIYQ | 66 | Q99707 | |
| LSFTVEELQIYQQGP | 126 | Q9BSH3 | |
| PIQDILSAFSVYVNN | 401 | O43490 | |
| NLNQPIEVTALYSFE | 281 | Q96HL8 | |
| FVQVNSPLQALYLEV | 866 | Q96PQ0 | |
| QVYVSQSAAAQIPAF | 2376 | Q9Y520 | |
| AVLQVIQTPQGTYVQ | 196 | P86478 | |
| TFTTPVQINQYGIVQ | 471 | Q9UIU6 | |
| PIVAFQTIINNASYN | 311 | Q7Z333 | |
| QSLFVLDENSYPLQQ | 801 | Q86V20 | |
| FTSVPQGQDLQYIFI | 216 | Q9UJ37 | |
| QFGSQPQVYNDFLDI | 136 | Q96ST3 | |
| NTEVAEAQQALYPVQ | 1111 | Q149N8 | |
| PQIILSQFADNTTYA | 181 | O15457 | |
| LEFVQQAQSLTPQDY | 371 | Q96M27 | |
| YQDGNLNISIPVFSI | 111 | P49959 | |
| IAPTKNEQQLFYISQ | 251 | P49959 | |
| SNSALQFVNYPTQVL | 101 | P78383 | |
| APVQYFVATKLSQAQ | 471 | Q09428 | |
| QVFPYPSVLNEEQTQ | 86 | P49748 | |
| ELDIPQSVQQNGSIY | 151 | O96005 | |
| VPTVVVLNTSNQQYF | 306 | Q96JJ7 | |
| FIQLNRISYPVNITS | 491 | Q9P2K2 | |
| ILQNDVQEFIPYVFQ | 651 | P55060 | |
| LYSNTLNFQISEVEP | 121 | Q9BSU3 | |
| NAITFSNRPVLIYEQ | 91 | O76050 | |
| FVRDVLQPYVQESQN | 231 | Q658P3 | |
| NFQIQAAEPTPTQVY | 341 | Q02086 | |
| SSVQYQVIPQIQSAD | 166 | Q02447 | |
| QETFYQQVKQLSEAP | 111 | Q9BSI4 | |
| SLTNEVNVAPSVINY | 461 | Q9BSK1 | |
| QQPLIYQNAATSFQV | 166 | Q12772 | |
| YQNAATSFQVLQPQV | 171 | Q12772 | |
| FVVQYEDTNGQPQAL | 3586 | P22105 | |
| ETQVPVSQQNLHSFY | 881 | Q6N022 | |
| FLYQPEAVQVFLQQS | 451 | Q96DC7 | |
| FISVTAYQNPQITQL | 246 | O95947 | |
| IYQEFLSSQALSPVN | 121 | O43566 | |
| STVVFEYPLNIQNIN | 1991 | Q86WI1 | |
| LQFPNYSSELNVNAL | 86 | A0A0C4DH59 | |
| LNVIQQTTRYFNTPQ | 201 | Q8N7R0 | |
| NAVNVVVPSVINYVL | 511 | Q9GZX5 | |
| VLNTQPAEEEYFINQ | 61 | Q92889 | |
| QNPVVTKNIAFNYIL | 2821 | Q70CQ2 | |
| TTQQPQAYNLFLTTA | 716 | A2RRH5 | |
| DQNLFTSVYPTLSQQ | 26 | P48553 | |
| QSQQPIYSKQSVFFV | 996 | P48553 | |
| VPIVQSAQSGQLFDY | 441 | P13866 | |
| VPQNYISDSLAQSVV | 76 | A3KMH1 | |
| AQQGPFYVTNVLEIN | 2081 | Q5T4S7 | |
| PQFLSIQEGENLTVY | 26 | A0A087WT01 | |
| QFQALLQYADPVSAQ | 221 | P26599 | |
| YALQIVANSFLANPT | 666 | Q9Y4A5 | |
| NVSYAPQNLAISIFF | 231 | Q08ET2 | |
| VNIAQTPAELYNAIL | 141 | P61421 | |
| AEVNVPGQIYSSQQL | 606 | Q9BYP7 | |
| VRPNQQEYKISSFEQ | 896 | Q86TC9 |